Literature DB >> 3529396

Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme.

R S Munford, C L Hall.   

Abstract

Lipopolysaccharides in the cell walls of Gram-negative bacteria elicit toxic as well as potentially beneficial inflammatory responses in animals. It is now reported that tissue toxicity caused by lipopolysaccharides is preferentially reduced by an enzymatic activity in human neutrophils. Acyloxyacyl hydrolysis removes fatty acyl chains that are linked to the hydroxyl groups of 3-hydroxytetradecanoyl residues in the bioactive lipid A moiety of the lipopolysaccharides. Maximal acyloxyacyl hydrolysis reduced lipopolysaccharide tissue toxicity, as measured in the dermal Shwartzman reaction, by a factor of 100 or more. In contrast, the ability of the deacylated lipopolysaccharides to stimulate B lymphocytes to divide was decreased only by a factor of 12. It is suggested that during tissue invasion by Gram-negative bacteria acyloxyacyl hydrolysis may be a defense mechanism that reduces the toxicity of lipopolysaccharides while preserving some of their potentially beneficial inflammatory and immune stimuli.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3529396     DOI: 10.1126/science.3529396

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  72 in total

1.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 2.  Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors.

Authors:  Andrea Comba; Yi-Hui Lin; Aldo Renato Eynard; Mirta Ana Valentich; Martín Ernesto Fernandez-Zapico; Marìa Eugenia Pasqualini
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 3.  Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Authors:  Robert S Munford; Jerrold P Weiss; Mingfang Lu
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

Review 4.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

5.  Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.

Authors:  Lutz Hamann; Christian Alexander; Cordula Stamme; Ulrich Zähringer; Ralf R Schumann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay.

Authors:  J Mertsola; R S Munford; O Ramilo; X Sáez-Llorens; M M Mustafa; G H McCracken; E J Hansen
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.

Authors:  M Andersson; R Girard; P Cazenave
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.

Authors:  Ryan G Snodgrass; Shurong Huang; Il-Whan Choi; John C Rutledge; Daniel H Hwang
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

Authors:  R L Danner; K A Joiner; J E Parrillo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice.

Authors:  K R Coenen; M L Gruen; R S Lee-Young; M J Puglisi; D H Wasserman; A H Hasty
Journal:  Diabetologia       Date:  2008-12-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.